TAVERNA, Daniela
TAVERNA, Daniela
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner
2012-01-01 Gagliardi PA; di Blasio L; Orso F; Seano G; Sessa R; Taverna D; Bussolino F; Primo L
A direct test of potential roles for b3 and b5 integrins in growth and metastasis of murine mammary carcinomas.
2005-01-01 D. TAVERNA; CROWLEY D; CONNOLLY M; BRONSON RO AND RICHARD HYNES
A test of the role of alpha5 integrin/fibronectin interactions in tumorigenesis.
1998-01-01 D. TAVERNA; ULLMAN-CULLERE M; RAYBURN H; BRONSON RT; HYNES RO
Acquired resistance to clinical cancer therapy: A twist in physiological signaling
2016-01-01 Wicki, Andreas; Mandalà, Mario; Massi, Daniela; Taverna, Daniela; Tang, Huifang; Hemmings, Brian A.; Xue, Gongda
ACTIVATOR PROTEIN-2 ALPHA TRANSCRIPTION FACTOR ROLES IN NEURONS
2004-01-01 ORSO F; MENINI N; DE BORTOLI M; TAVERNA D
AGO2 promotes telomerase activity and interaction between the telomerase components TERT and TERC
2019-01-01 Laudadio, Ilaria*; Orso, Francesca; Azzalin, Gianluca; Calabrò, Carlo; Berardinelli, Francesco; Coluzzi, Elisa; Gioiosa, Silvia; Taverna, Daniela; Sgura, Antonella; Carissimi, Claudia; Fulci, Valerio
Alemtuzumab long-lasting immunological effects: a 48 months follow-up observation
2016-01-01 Durelli, L; De Mercanti, SF; Cucci, A; Taverna, D; Rolla, S; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Horakova, D; Annovazzi, P; Novelli, F; Clerico, M
Alemtuzumab treatment in MS how do the Treg cell function and suppressor cytokine mRNA (IL-10, TGF-beta, IL_27) levels change? 24-month immunological report during 323 and 324 genzyme trials
2012-01-01 De Mercanti, S.; Cucci, A.; Viglietti,E.; Giai Via,A.; Taverna, D.; Cimino,D.;Rolla, S.; Bardina,V.; Novelli, F.; Vargas,J.; Gibbin,M.; Piazza,F.; Vladic,A.; Brina.V.; Habek,M.; Cocco,E.; Annavazzi,P.; Horakova,D.; Clerico, M.; Durelli, L.
Analysis of the regulatory regions of AP-2alpha-modulated genes selected for oral presentation and winner of the "Premio Chiara D'Onofrio Giovani Riercatori 2009"
2009-01-01 ORSO F; CORA D; UBEZIO B; PROVERO P; CASELLE M; TAVERNA D
Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma
2019-01-01 Vitiello, Marianna; Evangelista, Monica; Di Lascio, Nicole; Kusmic, Claudia; Massa, Annamaria; Orso, Francesca; Sarti, Samanta; Marranci, Andrea; Rodzik, Katarzyna; Germelli, Lorenzo; Chandra, Dinesh; Salvetti, Alessandra; Pucci, Angela; Taverna, Daniela; Faita, Francesco; Gravekamp, Claudia; Poliseno, Laura
AP-2alpha regulates migration of GN-11 neurons via a specific genetic programme involving the Axl receptor tyrosine kinase
2009-01-01 Orso F; Jager R; Calogero R.A.; Schorle H; Sismondi P; De Bortoli M; Taverna D
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs
2008-01-01 ORSO F; PENNA E; CIMINO D; ASTANINA E; MAIONE F; VALDEMBRI D; GIRAUDO E; SERINI G; SISMONDI P; DE BORTOLI M; TAVERNA D
Application of microcomputer-aided image analysis and immunocytochemical (ICC) methods to studies on the colocalization of neuroactive substances in the central nervous system (CNS).
1989-01-01 P. PUTZOLU; S. FERRARESI; M. RABINO; D. TAVERNA; G. BORDINI, A. FASOLO
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression
2020-01-01 Quirico L.; Orso F.; Esposito C.L.; Bertone S.; Coppo R.; Conti L.; Catuogno S.; Cavallo F.; Franciscis V.; Taverna D.
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy.
2015-01-01 Petrelli, A; Carollo, R; Cargnelutti, M; Iovino, F; Callari, M; Cimino, D; Todaro, M; Mangiapane, Lr; Giammona, A; Cordova, A; Montemurro, F; Taverna, D; Daidone, Mg; Stassi, G; Giordano, S.
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells
2018-01-01 Bellazzo, Arianna; Di Minin, Giulio; Valentino, Elena; Sicari, Daria; Torre, Denis; Marchionni, Luigi; Serpi, Federica; Stadler, Michael B.; Taverna, Daniela; Zuccolotto, Gaia; Montagner, Isabella Monia; Rosato, Antonio; Tonon, Federica; Zennaro, Cristina; Agostinis, Chiara; Bulla, Roberta; Mano, Miguel; Del Sal, Giannino; Collavin, Licio
Characterization of the cellular functions of KRIT1, the disease gene responsible for type 1 Cerebral Cavernous Malformations (CCM1)
2007-01-01 AVOLIO M; FRANCALANCI F; DEGANI S; BALZAC F; GOITRE L; DE LUCA E; MARINO M; RECUPERO D; ORSO F; TAVERNA D; RETTA S
CircuitsDB: a database of mixed microRNA/transcription factor feed-forward regulatory circuits in human and mouse
2010-01-01 Friard O; Re A; Taverna D; De Bortoli M; Corá D.
Co-localization of AP2alpha transcription factor and TH-immunoreactive neurons in mouse locus coeruleus
2004-01-01 Patrizi A.; Orso F.; Sica M.; Taverna D.; De Bortoli M.; Panzica G.C.
Co-occurrence of substance P and enkephalin-like immunoreactivities in the prosencephalon of two amphibians.
1993-01-01 D. TAVERNA; B. MULATERO; A. FASOLO
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner | 2012 | Gagliardi PA; di Blasio L; Orso F; Seano G; Sessa R; Taverna D; Bussolino F; Primo L | |
| A direct test of potential roles for b3 and b5 integrins in growth and metastasis of murine mammary carcinomas. | 2005 | D. TAVERNA; CROWLEY D; CONNOLLY M; BRONSON RO AND RICHARD HYNES | |
| A test of the role of alpha5 integrin/fibronectin interactions in tumorigenesis. | 1998 | D. TAVERNA; ULLMAN-CULLERE M; RAYBURN H; BRONSON RT; HYNES RO | |
| Acquired resistance to clinical cancer therapy: A twist in physiological signaling | 2016 | Wicki, Andreas; Mandalà, Mario; Massi, Daniela; Taverna, Daniela; Tang, Huifang; Hemmings, Brian A.; Xue, Gongda | |
| ACTIVATOR PROTEIN-2 ALPHA TRANSCRIPTION FACTOR ROLES IN NEURONS | 2004 | ORSO F; MENINI N; DE BORTOLI M; TAVERNA D | |
| AGO2 promotes telomerase activity and interaction between the telomerase components TERT and TERC | 2019 | Laudadio, Ilaria*; Orso, Francesca; Azzalin, Gianluca; Calabrò, Carlo; Berardinelli, Francesco; Coluzzi, Elisa; Gioiosa, Silvia; Taverna, Daniela; Sgura, Antonella; Carissimi, Claudia; Fulci, Valerio | |
| Alemtuzumab long-lasting immunological effects: a 48 months follow-up observation | 2016 | Durelli, L; De Mercanti, SF; Cucci, A; Taverna, D; Rolla, S; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Horakova, D; Annovazzi, P; Novelli, F; Clerico, M | |
| Alemtuzumab treatment in MS how do the Treg cell function and suppressor cytokine mRNA (IL-10, TGF-beta, IL_27) levels change? 24-month immunological report during 323 and 324 genzyme trials | 2012 | De Mercanti, S.; Cucci, A.; Viglietti,E.; Giai Via,A.; Taverna, D.; Cimino,D.;Rolla, S.; Bardina,V.; Novelli, F.; Vargas,J.; Gibbin,M.; Piazza,F.; Vladic,A.; Brina.V.; Habek,M.; Cocco,E.; Annavazzi,P.; Horakova,D.; Clerico, M.; Durelli, L. | |
| Analysis of the regulatory regions of AP-2alpha-modulated genes selected for oral presentation and winner of the "Premio Chiara D'Onofrio Giovani Riercatori 2009" | 2009 | ORSO F; CORA D; UBEZIO B; PROVERO P; CASELLE M; TAVERNA D | |
| Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma | 2019 | Vitiello, Marianna; Evangelista, Monica; Di Lascio, Nicole; Kusmic, Claudia; Massa, Annamaria; Orso, Francesca; Sarti, Samanta; Marranci, Andrea; Rodzik, Katarzyna; Germelli, Lorenzo; Chandra, Dinesh; Salvetti, Alessandra; Pucci, Angela; Taverna, Daniela; Faita, Francesco; Gravekamp, Claudia; Poliseno, Laura | |
| AP-2alpha regulates migration of GN-11 neurons via a specific genetic programme involving the Axl receptor tyrosine kinase | 2009 | Orso F; Jager R; Calogero R.A.; Schorle H; Sismondi P; De Bortoli M; Taverna D | |
| AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs | 2008 | ORSO F; PENNA E; CIMINO D; ASTANINA E; MAIONE F; VALDEMBRI D; GIRAUDO E; SERINI G; SISMONDI P; DE BORTOLI M; TAVERNA D | |
| Application of microcomputer-aided image analysis and immunocytochemical (ICC) methods to studies on the colocalization of neuroactive substances in the central nervous system (CNS). | 1989 | P. PUTZOLU; S. FERRARESI; M. RABINO; D. TAVERNA; G. BORDINI, A. FASOLO | |
| Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression | 2020 | Quirico L.; Orso F.; Esposito C.L.; Bertone S.; Coppo R.; Conti L.; Catuogno S.; Cavallo F.; Franciscis V.; Taverna D. | |
| By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy. | 2015 | Petrelli, A; Carollo, R; Cargnelutti, M; Iovino, F; Callari, M; Cimino, D; Todaro, M; Mangiapane, Lr; Giammona, A; Cordova, A; Montemurro, F; Taverna, D; Daidone, Mg; Stassi, G; Giordano, S. | |
| Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells | 2018 | Bellazzo, Arianna; Di Minin, Giulio; Valentino, Elena; Sicari, Daria; Torre, Denis; Marchionni, Luigi; Serpi, Federica; Stadler, Michael B.; Taverna, Daniela; Zuccolotto, Gaia; Montagner, Isabella Monia; Rosato, Antonio; Tonon, Federica; Zennaro, Cristina; Agostinis, Chiara; Bulla, Roberta; Mano, Miguel; Del Sal, Giannino; Collavin, Licio | |
| Characterization of the cellular functions of KRIT1, the disease gene responsible for type 1 Cerebral Cavernous Malformations (CCM1) | 2007 | AVOLIO M; FRANCALANCI F; DEGANI S; BALZAC F; GOITRE L; DE LUCA E; MARINO M; RECUPERO D; ORSO F; TAVERNA D; RETTA S | |
| CircuitsDB: a database of mixed microRNA/transcription factor feed-forward regulatory circuits in human and mouse | 2010 | Friard O; Re A; Taverna D; De Bortoli M; Corá D. | |
| Co-localization of AP2alpha transcription factor and TH-immunoreactive neurons in mouse locus coeruleus | 2004 | Patrizi A.; Orso F.; Sica M.; Taverna D.; De Bortoli M.; Panzica G.C. | |
| Co-occurrence of substance P and enkephalin-like immunoreactivities in the prosencephalon of two amphibians. | 1993 | D. TAVERNA; B. MULATERO; A. FASOLO |